Mark William Lowdell

CIK: 0001767037

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (7.1%)

Derivative conversions

Awards (A)7 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)6 (42.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INMB

Inmune Bio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

INMB
Inmune Bio, Inc.
Jul 2, 2026
In-the-Money(X)
Common Stock Purchase Warrant
Direct
7.2K shares at avg. $0.13-
INMB
Inmune Bio, Inc.
Jul 2, 2026
Exercise(M)
Direct
7.2K shares at avg. $1.40$10K
INMB
Inmune Bio, Inc.
Dec 1, 2025
Award(A)
Option (right to buy)
Direct
600K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
180K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
180K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
104K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
104K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
140K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
140K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
100K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
100K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Disposition(D)
Stock Option (right to buy)
Direct
400K shares-
INMB
Inmune Bio, Inc.
Nov 18, 2025
Award(A)
Stock Option (right to buy)
Direct
400K shares-
INMB
Inmune Bio, Inc.
Dec 5, 2024
Award(A)
Option (right to buy)
Direct
140K shares-

		Type	Shares	Price		Ownership
Jul 2, 2026	INMB Inmune Bio, Inc.	In-the-Money(X) Common Stock Purchase Warrant	7,211	$0.13	-	Direct
Jul 2, 2026	INMB Inmune Bio, Inc.	Exercise(M)	7,211	$1.40	$10,095	Direct
Dec 1, 2025	INMB Inmune Bio, Inc.	Award(A) Option (right to buy)	600,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	180,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	180,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	104,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	104,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	140,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	140,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	100,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	100,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Disposition(D) Stock Option (right to buy)	400,000	-	-	Direct
Nov 18, 2025	INMB Inmune Bio, Inc.	Award(A) Stock Option (right to buy)	400,000	-	-	Direct
Dec 5, 2024	INMB Inmune Bio, Inc.	Award(A) Option (right to buy)	140,000	-	-	Direct

1-14 of 14 transactions

About Lowdell Mark William

Lowdell Mark William (SEC CIK 0001767037) files insider reports with the SEC as Chief Scientific Officer of Inmune Bio, Inc. (INMB).

Signal8 holds 4 ownership filings by Lowdell Mark William, all Form 4s, filed between Dec 9, 2024 and Jul 7, 2026. Those filings report 14 transactions, from Dec 5, 2024 to Jul 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lowdell Mark William's filings is in BOCA RATON, FL.

Recent filings by Lowdell Mark William

Jul 2, 2026: Option exercise of INMB derivative securities (Form 4, code X).
Jul 2, 2026: Option exercise of INMB shares (Form 4, code M).
Dec 1, 2025: Grant or award of INMB derivative securities (Form 4, code A).
Nov 18, 2025: Disposition to issuer transaction of INMB derivative securities (Form 4, code D).
Nov 18, 2025: Grant or award of INMB derivative securities (Form 4, code A).

Other insiders filing for Inmune Bio, Inc. (INMB)

Clark Ronnie Duane, Director
SAPIRSTEIN JAMES, Director
Juda Scott, Director
Moss David J, Chief Executive Officer
Ellspermann Cory Randall, Interim CFO
Schroeder Timothy j, Director

How to read Form 4 transaction codes